The influence of immediate knee flexion on blood loss and other parameters following total knee replacement

• Published in: The bone & joint journal Vol. 96-B; no. 2; pp. 201 - 209
• Main Authors: Napier, R J, Bennett, D, McConway, J, Wilson, R, Sykes, A M, Doran, E, O'Brien, S, Beverland, D E
• Format: Journal Article
• Language: English
• Published: England 01.02.2014
• Subjects: Aged; Arthroplasty, Replacement, Knee; Blood Loss, Surgical - physiopathology; Blood Loss, Surgical - prevention & control; Blood Transfusion - methods; Female; Follow-Up Studies; Humans; Knee Joint - physiopathology; Male; Postoperative Period; Posture; Prospective Studies; Range of Motion, Articular - physiology; Treatment Outcome; Complications; Knee arthroplasty; Blood loss; Mobility; Post-operative; Neuropathy; Knee flexion
• ISSN: 2049-4394; 2049-4408
• DOI: 10.1302/0301-620x.96b2.32787

In an initial randomised controlled trial (RCT) we segregated 180 patients to one of two knee positions following total knee replacement (TKR): six hours of knee flexion using either a jig or knee extension. Outcome measures included post-operative blood loss, fall in haemoglobin, blood transfusion requirements, knee range of movement, limb swelling and functional scores. A second RCT consisted of 420 TKR patients randomised to one of three post-operative knee positions: flexion for three or six hours post-operatively, or knee extension. Positioning of the knee in flexion for six hours immediately after surgery significantly reduced blood loss (p = 0.002). There were no significant differences in post-operative range of movement, swelling, pain or outcome scores between the various knee positions in either study. Post-operative knee flexion may offer a simple and cost-effective way to reduce blood loss and transfusion requirements following TKR. We also report a cautionary note regarding the potential risks of prolonged knee flexion for more than six hours observed during clinical practice in the intervening period between the two trials, with 14 of 289 patients (4.7%) reporting lower limb sensory neuropathy at their three-month review.